Abstract
The purpose of this study was to analyze hepatobiliary samples of patients with biliary atresia for rotavirus groups A, B, and C, because group A rotavirus had been used to produce an animal model of the disease and group C rotavirus had been found in hepatobiliary samples from one group of patients. Biliary remnants and liver tissue from 10 biliary atresia and 14 control patients with other liver diseases were examined for rotavirus groups A, B, and C using nonisotopic, reverse transcriptase polymerase chain reaction enzyme immunoassay. Biliary atresia patients had a median age of 3 mo and were from a confined geographic area. Rotaviral stocks from groups A and C were used as polymerase chain reaction-positive controls. The limits of detection for rotaviral RNA from these two groups were, respectively, 5 plaque-forming units and 50 tissue culture infectious doses (ID50). Tissue culture was 100-fold less sensitive for groups A and C than the polymerase chain reaction. The nested, nonisotopic probes hybridized in solution only with their homologous target DNAs as determined by the enzyme immunoassay, or by Southern blot hybridization. Although it was possible to detect mRNA from aβ-actin housekeeping gene in all of the hepatobiliary samples, no evidence of rotaviral RNA was found in either the biliary atresia or the negative control group. In conclusion, rotavirus is not a common viral etiology of biliary atresia.
Similar content being viewed by others
Main
Although biliary atresia is the most common indication for liver transplantation during infancy, the cause of this serious disorder is unknown(1). During the first few weeks of clinically inapparent disease, liver histology is characterized by dense inflammatory infiltration with small numbers of polymorphonuclear leukocytes, lymphocytes, plasma cells, and eosinophils surrounding bile ducts(2). Later, mononuclear cells predominate. This presentation has prompted several investigators to seek a viral etiology, because the histology is consistent with a viral infection. Witzelben et al.(2) failed to find evidence of either CMV by viral culture or hepatitis B by immunofluorescence studies of fresh frozen sections of liver biopsy specimens from infants with the disorder. These authors recommended that an aggressive search for other viruses was warranted. A more recent study that used a sensitive PCR failed to find CMV in the majority of infants with biliary atresia(3). In addition, Balistreri et al.(4) reported negative serology for both hepatitis A and B in infants with biliary atresia.
In other studies, initial reports suggested that perinatal infection with reovirus 3 may be an initiating factor in both biliary atresia and idiopathic neonatal hepatitis(5). Indeed, infection in newborn mice with this virus resulted in periportal inflammation; however, bile duct epithelial damage was not observed(6). Other investigators failed to confirm a role for reovirus 3 in neonatal liver disease(7).
Recently, several lines of evidence have suggested an etiopathologic role for rotaviruses in biliary atresia. Rotaviruses are the most common cause of gastroenteritis in children and infants worldwide, with an estimated 140 million infected yearly and 1 million deaths(8). In addition, rotaviruses are the most common cause of nosocomially acquired gastroenteritis in children(9–11). Although GAR primarily infects mature enterocytes of the intestinal villi in humans, we reported the growth of simian and bovine GARs in a human liver cell line; however, these cells failed to support the growth of any human GAR(12). GAR (simian and human) produced extrahepatic biliary obstruction in orally inoculated newborn mice(13). Bile ducts from infected mice showed variable degrees of inflammation and fibrosis but without atresia of the extrahepatic biliary tract, characteristic of biliary atresia in human infants. In a recent report, GAR in liver samples from 14 infants with biliary atresia was not detected using PCR followed by liquid hybridization employing a probe for VP7, the outer capsid neutralization protein(14). However, 71% of the patients in the same study were positive for either gene 5 or 6 of GCR using a nested PCR or by liquid hybridization with radiolabeled probes to assay liver and bile duct samples.
The present study was undertaken to determine whether rotavirus A, B, or C could be detected in liver and bile duct remnants of biliary atresia patients from our geographic area. Detection tests, such as antigen immunoassay, immune electron microscopy, and PAGE are insensitive, generally requiring more than 107 virions/g of sample(15, 16). In clinical and subclinical infections, viral titers are well below this(17). Previous studies have shown PCR to be more sensitive for detection of a wide range of infectious agents, including rotavirus A(18–21). We have reported that detection of amplified DNA:biotinylated RNA hybrids using a quantitative EIA format (PCR-EIA) to be highly sensitive and specific for other pathogens(22–25). Therefore, we developed an individual RT-PCR-EIA for each GAR, GBR, and GCR to maximize our ability to detect these agents in liver samples from biliary atresia patients.
METHODS
Patient selection. Ten children with biliary atresia were selected consecutively. The diagnosis of biliary atresia was established by operative cholangiography, which demonstrated absence of a lumen in part or all of the extrahepatic biliary tract. All of the children had the“acquired” form of biliary atresia, without other anomalies. Liver biopsies were obtained either at the time of diagnosis (n = 6), at the time of orthotopic transplant (n = 3), or during an episode of ascending cholangitis (n = 1). Liver was obtained from all patients, and biliary remnants from five for a total of 15 samples. The “biliary remnants” in two patients were gallbladder tissue (from children in whom a gallbladder Kasai portoenterostomy procedure was performed), and in three patients they were the portal plates of scar tissue removed at the time of the Kasai procedure. The controls were children (n = 14) with a variety of liver diseases. Liver biopsies were obtained by percutaneous needle biopsy(n = 9) or intraoperatively at the time of orthotopic liver transplant (n = 5). Patient information is described in Table 1. None of the patients had a history of rotavirus or other gastroenteritides. The history of maternal infection during pregnancy is unknown. In all cases, liver samples were frozen when obtained by immersion in liquid nitrogen or dry ice and then stored at -70°C until analyzed. The study was approved by the Johns Hopkins Committee on Clinical Investigation, and informed consent was obtained from the parents.
Laboratory procedures. Tissue samples were thawed on ice, and a portion was minced cold in diethylpyrocarbonate water. Other aliquots were stored at -70°C. Total RNA was extracted using the guanidinium isothiocyanate-acid phenol method(26). Negative control buffers were included every third sample. Because rotaviral RNA is double-stranded, RNA was heated to 95°C for 5 min and then chilled. Reverse transcription was performed in a 20-μL final volume at 37°C for 1 h, boiling for 5 min, and snap-cooling on ice. RT reagents were RT buffer(50 mM Tris-HCl, pH 8.3, 50 mM KCl, 8 mM MgCl2), 1 mM RNasin, 5 μg of random hexamers, 100 U of Moloney murine leukemia virus RT, and 3 μL of boiled RNA. A second RNA aliquot, which was processed for β-actin mRNA, was not first preheated because β-actin mRNA is single-stranded. This aliquot was reverse transcribed in a separate RT-PCR. The β-actin sample served as a control for integrity of sample RNA.
Positive controls used for development of the RT-PCR-EIA were extracted MA-104 cells infected with rotavirus A (human strains ATCC VR-954, and Wa, ATCC VR-2018) (American Type Culture Collection, Rockville, MD), which were grown in our laboratory to moderate and high titers. Infected infant rat feces was the source of RNA for GBR (strain IDIR), and MA-104 cells were used to propagate a GCR porcine isolate (Cowden strain). The IDIR and Cowden strains were gifts from Drs. J. Eiden (Johns Hopkins University) and L. Saif (Ohio State University), respectively. In addition, a human strain of GCR isolated from a patient with diarrhea was also used as a positive control for the PCR.
PCR primers were chosen in areas of the genome which are conserved between animal species, including humans. Primers for DNA amplification are listed in the order of sense and antisense: GAR, gene 6, bp 1-20: GGCTTTTAAACGAAGTCTTC; bp 234-259: TCAACATAATTAGCGTCTAAGTTCA(27); GBR, gene 3, bp 898-920: ATCATGGAGGCCGGCCACAGACT; bp 1150-1175: CTAGGAAGT-ATCTATCTGTGCAAAGCC(28); GCR, gene 6, bp 994-1016: CTCGATGTCACTACAGAATCAG; bp 1327-1349: AGCCACATAGTTCACATTTTCATCC(29); β-actin: exon-1, bp 2-23: TGGATGATGATATCGCCGCG; exon-2, bp 467-489: CATCTTCTCGCGGTTGGCCTTG(30). Three microliters of cDNA were added to 47 μL of PCR buffer (10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl2), 0.2 mM of dNTPs, 0.5 μM final concentration of primers, and 1.25 U of Taq DNA polymerase (Amplitaq, Perkin-Elmer, Norwalk, CT) in a 50-μL final volume. The thermofile was an initial 5 cycles of 94°C, 55°C and 72°C for 1 min each, followed by 25 more cycles of 30 s for each temperature. Ten microliters of product were electrophoresed through 7.5% polyacrylamide gel(PAGE) followed by staining with silver nitrate(31).
Biotinylated RNA probes for each organism were transcribed from amplified DNA using primers completely nested to the external primers listed above. A standard transcription reaction described previously was performed on 500 ng of DNA using T7 RNA polymerase and biotin-11-UTP (Enzo, Farmingdale, NY)(22). Nested primers are listed as sense and antisense, and the sense primer contains the T7 RNA polymerase promoter, which is underlined: GAR: 48-60 bp TTAATACGACTCACTATAGGGT TGTCAAAGAACTCTTAAAG; 168-187 bp GGCAAATTACCCATTCCTCC; GBR: 929-948 bp, T7 promoter CAGTTCACGCTTCAACC; 1102-1122 bp, CCGCCCTTATTGGTTATTCCC; GCR: 1084-1118 bp, T7 promoter GGAAACAGTATTTCAGCCA; 1295-1316 bp, TCATCCACGTCATGCGCATTTG.
Solution hybridization of the amplified DNA with the biotinylated RNA probe was detected by an EIA as described previously(22). Briefly, biotinylated hybrids were captured in anti-biotin-coated microtiter plate wells and reacted to a MAb to RNA:DNA hybrids that was conjugated to alkaline phosphatase. Cleavage of the phosphorylated substrate yielded a fluorescent signal (FU), which was measured in a fluorometer. Samples were considered positive if the mean FU value of duplicate wells was greater than the mean of negative reagent controls plus 3 SD. This cutoff value derived from the reagent controls is subtracted from the sample values so that a value>0 FU would be considered positive.
Probes were tested with amplified DNA from approximately 105-106 plaque-forming units or tissue culture ID50 of GAR or GCR in homologous and heterologous hybridizations to determine specificity. Several dilutions of GBR were also tested. Nested primers were used to amplify each rotavirus stock strain in homologous and heterologous amplification reactions. Ethidium bromide-stained 2.0% agarose gel was used to analyze the results. Sensitivity of RT-PCR-EIA was determined on 10-fold dilutions of tissue-cultured stock strains of GAR and GCR that were each extracted and amplified.
Solid phase hybridization and detection was carried out for GCR only after Southern blot(32) of amplified samples using enhanced chemiluminescence (ECL, Amersham Corp., Arlington Heights, IL). An internal oligo probe (the nested antisense primer) was 3′-labeled with fluorescein-11-dUTP and hybridized according to the manufacturer's directions.
Several types of laboratory controls were included in this study. We monitored PCR contamination using both extraction and PCR-negative buffer and negative tissue cultured cells. If PCR products were detected concurrently in negative controls and test samples, the test was considered invalid. In this case, another frozen test sample from the same patient would be processed for reanalysis. To control for quality of tissue RNA and cDNA, a β-actin PCR was performed on each human sample, and the PCR was examined by silver-stained PAGE. Positive rotavirus samples were also included throughout the analysis, which would give a band intensity equivalent to 1 ng of DNA and a moderate EIA value of approximately 500 FU. The GCR PCR-positive control also served as the Southern blot-hybridization control.
RESULTS
Initial studies comparing sensitivity of tissue culture with RT-PCR-EIA on serial 10-fold dilutions of GAR and GCR rotavirus indicated that PCR was consistently 100-fold more sensitive than tissue culture. In addition, EIA fluorescence values were directly related to viral load and were linear over most of the 10-fold dilutions (Fig. 1). The cutoff was determined from the mean of 3 negative tissue culture samples plus 3 SD. Because GBR is not cultivable, we could not employ the same method of comparison. However, based on past RT-PCR studies by this laboratory on dilutions of purified GBR RNA using acrylamide gel detection, the limit of detection was 8 attamoles or 400 genome equivalents(21).
Specificity was determined in two ways. First, each nested primer set reacted only with its homologous target (Fig. 2). Second, a target DNA, which was generated using external primers, reacted only with its homologous probe and not with the heterologous probes. Input target was approximately 103-102.5 plaque-forming units or tissue culture ID50 for GAR and GCR, respectively, and the cutoff was determined as mentioned previously.
β-Actin mRNA was present in all of the liver samples from both biliary atresia patients and control patients by RT-PCR as seen by detection of a 342-bp (as calculated from cDNA) amplified DNA band by gel. β-Actin mRNA was also detected in the biliary remants from biliary atresia patients 3 and 4 and gallbladder from biliary atresia patient 10 but not from the biliary remnants of biliary atresia patient 1 nor from the gallbladder of biliary atresia patient 5. However, despite the fact that β-actin mRNA was present in all of the liver samples, demonstrating that RNA was present in these samples, RT-PCR was negative for all of the rotavirus groups on all of the samples from both biliary atresia patients and control patients by both gel (Fig. 3A) and EIA detection (FU < 0). In comparison, EIA values for positive viral controls for GAR, GBR, and GCR were 454 ± 8, 395 ± 57, and 685 ± 10 FU, respectively. In addition to a PCR-EIA analysis on test samples for GCR, we also performed a Southern blot of the same amplified samples. Hybridization with an internal oligonucleotide was negative for the biliary atresia patients and liver disease control patients but strongly positive for the GCR control (Fig. 3B).
DISCUSSION
RT-PCR-EIA was developed for GAR, GBR, and GCR and found to be highly sensitive and specific. In previous studies on other viral and bacterial pathogens, we have shown EIA detection of amplified DNA to be consistently 100-fold more sensitive than silver-stained acrylamide gel detection and equivalent to radioactive hybridization of Southern blot(19, 22). In addition, the sensitivity and specificity of the biotinylated probe in a solution hybridization-EIA was equivalent to either a radiolabeled or chemiluminescent probe hybridization of a Southern blot. Moreover, the efficiency of RNA extraction and RT-PCR-EIA was monitored by inclusion of a rotavirus sample which would reproducibly give a moderately positive signal. Finally, in past studies on Chlamydia trachomatis using animal models(33) and in transmission studies between partners(34), and in human volunteer studies for influenzae A and parainfluenzae 3 vaccine efficacy(24, 25), we have demonstrated that it was possible to detect amplified DNA when traditional tests were negative. Therefore, we are assured that PCR-EIA is highly sensitive and specific.
The fact that our series of samples was negative for GCR by RT-PCR as well as by Southern blot contradicts the report by Riepenhoff-Talty et al.(14) of 71% positivity for this virus. Although both genes 5 and 6 of GCR were tested in the Riepenhoff-Talty study, it was reported that at least one gene was positive by either liquid hybridization with a radiolabeled probe or by nested PCR. If GCR were etiologic for the cases of biliary atresia studied by these investigators, and if both PCRs were equally efficient, one would assume that both genes should have been detected. Because Riepenhoff-Talty et al. did not identify their primers, we were unable to compare their primer sites with those chosen for our study. The primer sites that we chose for group C PCR were in areas that are known to be conserved between human, bovine, and porcine strains(35, 36).
In our experience, nested PCR is prone to contamination. Furthermore, in studies where we have reported much higher positivity rates than expected, or compared with “gold standard” detection methods, DNA sequencing of the PCR products from a gene segment with known variability has helped us to validate our findings in terms of discounting PCR contamination(34). An alternate possibility to explain the discrepancy between the Riepenhoff-Talty results and our own is that the scientific methodology used by both groups was equally accurate, but that GCR prevalence was defined by differing geographies. At least one group of investigators has noted time-space clustering of biliary atresia cases(37), suggesting that geographic and seasonal factors may play a role. In addition, it should be noted that there has been considerable controversy surrounding a putative association between biliary atresia and a variety of viral agents, including most notably reovirus-3, but also hepatitis B, CMV, and respiratory syncytial virus(38–42)
Our study could be criticized because four of the hepatobiliary samples were obtained at the time of transplant (13, 17, and 19 mo and 10 y of age), long after the initial putative viral insult. However, some investigators(43, 44) have proposed that, in studies of possible viral etiologies of biliary atresia, hepatobiliary samples should be studied for evidence of residual viral nucleic acids. The rationale for this approach is that progression of hepatobiliary pathology after portoenterostomy could be attributed to persistence of a virus and/or the immune response to it. Another criticism of our study is that β-actin could not be detected in the biliary remnants of patients 1 or 5, so consideration could be given to discounting the rotavirus PCR studies in those samples. On the other hand, it was possible to detect β-actin in the liver samples of those two patients. Because the biliary samples were harvested and stored the same way as the liver samples, neither the failure to detect β-actin nor the significance of this failure is easily understood.
A third criticism of our study is that the number of biliary remnants was small and that liver samples might not be of value in studying a disease that primarily affects biliary epithelium. On the other hand, we had previously demonstrated that it is possible to cultivate GARs in human-derived liver(HepG2) cells(12). Furthermore, Uhnoo et al.(45) showed that rotavirus could be detected in the livers of mice inoculated orally with rhesus rotavirus. Taken together, these findings suggest that liver samples as well as biliary samples might be useful in investigating the role of rotaviruses in hepatobiliary diseases such as biliary atresia.
In conclusion, our data, like those of Riepenhoff-Talty et al.(14), fail to support a role for GAR in the pathogenesis of biliary atresia. In addition, our data fail to support a role for either GBR or GCR as common etiopathologic agents in biliary atresia in human infants. Our findings reinforce the concept that large scale multicenter studies will be necessary before a firm link can be established between any putative viral agent and biliary atresia. In addition, the discrepancy between Riepenhoff-Talty et al.'s results and our own is entirely consistent with the “two-hit” model of biliary atresia proposed by Schreiber et al.(46). In this model, a variety of environmental factors such as diverse viral infections would act on a genetically susceptible host(47) to stimulate production of neoantigens by biliary epithelium(48), which would be followed by a cellular immune fibrosclerosing injury to the bile ducts. This model suggests that future investigations of the etiology of biliary atresia should include the host immune response as well as a search for etiologic agents.
Abbreviations
- RT:
-
reverse transcriptase
- PCR:
-
polymerase chain reaction
- EIA:
-
enzyme immunoassay
- CMV:
-
cytomegalovirus
- GAR:
-
group A rotavirus
- GBR:
-
group B rotavirus
- GCR:
-
group C rotavirus
- FU:
-
fluorescence units
References
Busutil RW, Brehms JJ, Hiatt JR 1988 Pediatric liver transplantation. In: Maddrey WC (eds) Transplantation of the Liver. Elsevier, New York, pp 309–330
Witzelben CL, Buck BE, Schnaufer L, Brzosko WJ 1978 Studies of the pathogenesis of biliary atresia. Lab Invest 38: 525–532
Chang MH, Huang HH, Huang ES, Kao CL, Hsu HY, Lee CY 1992 Polymerase chain reaction to detect human cytomegalovirus in livers of infants with neonatal hepatitis. Gastroenterology 103: 1022–1025
Balistreri WF, Tabor E, Gerety RJ 1980 Negative serology for hepatitis A and B viruses in 18 cases of neonatal cholestasis. Pediatrics 66: 269–271
Glaser JH, Balistreri WF, Morecki R 1984 Role of reovirus type 3 in persistent infantile cholestasis. J Pediatr 105: 912–915
Parashar K, Tarlow MJ, McCrae MA 1992 Experimental reovirus type-3 induced murine biliary tract disease. J Pediatr Surg 27: 843–847
Brown WR, Sokol RJ, Levin MJ, Silverman A, Tamaru T, Lilly JR 1988 Lack of correlation between infection with reovirus 3 and extrahepatic biliary atresia or neonatal hepatitis. J Pediatr 113: 670–676
Institute of Medicine 1985 Prospects for Immunizing against Rotavirus. National Academy Press, Washington, DC
Dennehy PH, Peter G 1985 Risk factors associated with nosocomial rotavirus infection. Am J Dis Child 139: 935–939
Ringenbergs ML, Davidson GP, Spence J, Morris S 1989 Prospective study of nosocomial rotavirus infection in a pediatric hospital. Aust Pediatr J 25: 156–160
Raad II, Shertz RJ, Russell BA, Reuman PD 1990 Uncontrolled nosocomial rotavirus transmission during a community outbreak. Am J Infect Control 18: 24–28
Schwarz KB, Moore TJ, Willoughby RE Jr, Wee S-B, Vonderfecht SL, Yolken RH 1990 Growth of group A rotavirus in a human liver cell line. Hepatology 12: 638–643
Riepenhoff-Talty M, Schaekel K, Clark HF, Mueller W, Uhnoo I, Rossi T 1993 Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res 33: 394–399
Riepenhoff-Talty M, Rossi T, Gouvea V 1993 Extrahepatic biliary atresia (EHBA) in human infants associated with group C rotavirus. Hepatology 18: 98A
Kapikian AZ, Chanock RM 1985 Rotaviruses. In: Fields BN, Knipe DM, Chanock RM, Melnick JL, Roizman B, Shope RE (eds) Virology. Raven Press, New York, pp 863–906
Miotti P, Eiden J, Yoken R 1985 Comparative efficiency of commercial immunoassays for the diagnosis of rotavirus gastroenteritis during the course of infection. J Clin Microbiol 22: 693–698
Ward RL, Bernstein DI, Young EC, Sherwood JR, Knowlton DR, Schiff GM 1986 Human rotavirus studies in volunteers:determination of infectious dose and serological response to infection. J Infect Dis 154: 871–880
Wilde J, Eiden J, Yolken R 1990 Removal of inhibitory substances from human fecal specimens for detection of group A rotaviruses by reverse transcriptase and polymerase chain reaction. J Clin Microbiol 27: 29–38
Wilde J, Yolken R, Willoughby R, Eiden J 1991 Improved detection of rotavirus shedding by polymerase chain reaction. Lancet 337: 323–326
Gouvea V, Allen JR, Glass RI, Fang Z-Y, Bremont M, Cohen J McCrae MA 1991 Detection of group B and C rotaviruses by polymerase chain reaction. J Clin Microbiol 29: 519–523
Eiden JJ, Wilde J, Firoozmand F, Yolken R 1991 Detection of animal and human Group B rotaviruses in fecal specimens by polymerase chain reaction. J Clin Microbiol 29: 539–543
Coutlee F, Bobo L, Mayur K, Yolken R, Viscidi R 1989 Immunodetection of DNA with biotinylated RNA probes: a study of reactivity of a monoclonal antibody to DNA-RNA hybrids. Anal Biochem 181: 96–105
Bobo L, Munoz B, Viscidi R, Quinn T, Mkocha H, West S 1991 Diagnosis of Chlamydia trachomatis ocular infection in Tanzania by polymerase chain reaction-enzyme immunoassay. Lancet 338: 847–850
Cherian T, Bobo L, Steinhoff MC, Karron RA, Yolken RH 1994 Detection of Influenza A virus matrix RNA by polymerase chain reaction/enzyme imunoassay (PCR-EIA): identification of RNA in clinical samples negative for cultivatable virus. J Clin Microbiol 32: 623–628
Karron RA, Froelich JL, Bobo L, Belshe RB, Yolken RH 1994 Rapid detection of Parainfluenzae type 3 viral RNA in respiratory specimens:use of the polymerase chain reaction/enzyme immunoassay (PCR-EIA). J Clin Microbiol 32: 484–488
Chomczynski PN, Sacchi N 1987 Single step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159
Estes MK, Mason BB, Crawford S, Cohen J 1984 Cloning and nucleotide sequence of the simian rotavirus gene 6 that codes for the major inner capsid protein. Nucleic Acids Res 12: 1875–1887
Sato S, Yolken RH, Eiden J 1989 The complete nucleic acid sequence of gene segment 3 of the IDIR strain of group B rotavirus. Nucleic Acids Res 17: 10113
Bremont M, Charbanne-Vautherot D, Vannier P, McCrae MA, Cohen J 1990 Sequence analysis of the gene (6) encoding the major capsid protein (VP6) of group rotavirus: higher than expected homology to the corresponding protein from group A rotavirus. Virology 178: 583–597
Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T 1985 Molecular structure of the human cytoplasmic β-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 82: 6133–6137
Herring AJ, Inglis NF, Ojeh CK, Snodgrass DR, Menzies JD 1982 Rapid diagnosis of rotaviral infection by direct detection of viral nucleic acid in silver-stained polyacrylamide gels. J Clin Microbiol 16: 473–477
Sambrook J, Fritsch EF, Maniatis T 1989 Molecular Cloning. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
Holland S, Hudson A, Whittum-Hudson J, Viscidi R, Quinn T, Taylor H 1992 Demonstration of chlamydia RNA and DNA during a culture-negative state. Infect Immun 60: 2040–2047
Viscidi R, Bobo L, Hook EL III, Quinn TC 1993 Transmission of Chlamydia trachomatis among sexual partners assessed by polymerase chain reaction. J Infect Dis 168: 488–492
Jiang BM, Tsunemitsu H, Qian Y, Green KY, Oseto M, Yamashita Y, Saif LJ 1992 Analysis of genetic diversity of genes 5 and 6 among group C rotavirus using cDNA probes. Arch Virol 45: 56
Qian Y, Jiang B, Saif LJ, Kang SY, Ishimani Y, Yamashita Y, Oseto M, Green KY 1991 Comparison of human and porcine group C rotaviruses and its relationship to the VP 7 gene of group A rotavirus. Virology 182: 562–569
Strickland AD, Shannon K 1982 Studies in the etiology of extrahepatic biliary atresia: time-space clustering. J Pediatr 100: 749–753
Brown WR. 1990 Lack of conformation of the association of reovirus 3 and biliary atresia: methodological differences. Hepatology 12: 1254–1255
Tanaka M, Ishikawa T, Sakaguchi M 1993 The pathogenesis of biliary atresia in Japan: immunohistochemical study of HBV-associated antigen. Acta Pathol Jpn 43: 360–366
Hart MH, Kaufmann SS, Vanderhoof JA, Erdman S, Linder J, Markin RS, Kruger R 1991 Neonatal hepatitis and extrahepatic biliary atresia associated with cytomegalovirus infection in twins. Am J Dis Child 145: 302–305
Groothuius JR, Salbenblatt CK, Lauer BA 1990 Severe respiratory syncytial virus infection in older children. Am J Dis Child 144: 346–348
Nadal D, Wunderli W, Meurmann O, Briner J, Hirsig J 1990 Isolation of respiratory syncytial virus from liver tissue and extrahepatic biliary atresia material. Scand J Infect Dis 22: 91–93
Morecki R, Glaser J 1988 Reovirus 3 and neonatal biliary disease: Discussion of divergent results. Hepatology 113: 670–676
Morecki R, Glaser JH, Cho S, Balistreri WF, Horwitz MS 1982 Biliary atresia and reovirus type 3 infection. N Engl J Med 307: 8:481-484
Uhnoo I, Riepenhoff-Talty M, Dharakul T, Chegas P, Fisher JE, Greenberg HB, Ogra PL 1990 Extramucosal spread and development of hepatitis in immunodeficient and normal mice infected with Rhesus rotavirus. J Virol 64: 361–368
Schreiber RA, Kleinman RE 1993 Genetics, immunology and biliary atresia:an opening or a diversion?. J Pediatr Gastroenterol Nutr 16: 111–113
Silveira TR, Salzano FM, Donaldson PT, Mieli-Vergani G, Howard ER, Mowat AP 1993 Association between HLA and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 16: 114–117
Harper P, Plant JW, Unger DB 1990 Congenital biliary atresia and jaundice in lambs and calves. Aust Vet J 67: 18–22
Acknowledgements
The authors thank Robert Dudas for technical support and Barbara Bishop for assistance with graphics.
Author information
Authors and Affiliations
Additional information
Supported by National Institutes of Health Fogarty International Fellowship 1 FO5 TWO 479 (C.O.).
Rights and permissions
About this article
Cite this article
Bobo, L., Ojeh, C., Chiu, D. et al. Lack of Evidence for Rotavirus by Polymerase Chain Reaction/Enzyme Immunoassay of Hepatobiliary Samples from Children with Biliary Atresia. Pediatr Res 41, 229–234 (1997). https://doi.org/10.1203/00006450-199702000-00013
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199702000-00013
This article is cited by
-
Maternal regulation of biliary disease in neonates via gut microbial metabolites
Nature Communications (2022)
-
Sclerosing and obstructive cholangiopathy in biliary atresia: mechanisms and association with biliary innate immunity
Pediatric Surgery International (2017)
-
Extrahepatische Gallenwegserkrankungen im Säuglingsalter
Monatsschrift Kinderheilkunde (2011)